Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019


 

Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAILORx and Prosigna Trials Affect Practice?

2,099 views
May 30, 2019
0 Comments
Login to view comments. Click here to Login
Updates in Oncology